临床,实验室和分子方面的V因子缺乏症
Massimo Franchini1, Daniele Focosi2
1Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantua, Italy.
Seminars in thrombosis and hemostasis
|August 27, 2024
概括
遗传V因子 (FV) 缺乏症是一种罕见的出血障碍,通过凝血测试和F5基因的遗传分析来诊断. 治疗包括新鲜冷的血,症状从轻微的伤到严重的出血变化.
科学领域:
- 血液学 血液学 血液学
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 因子V (FV) 对于血液静止至关重要,它调节了前凝和抗凝途径.
- 先天性FV缺陷是一种罕见的遗传性出血障碍,在百万分之一的出生中发生同卵性形式.
- F5基因含有各种突变 (错误,无意义,移) 导致FV缺陷.
研究的目的:
- 为遗传V因子缺乏症提供最新的审查.
- 涵盖关键的实验室,分子,临床和治疗方面.
- 为研究人员和临床医生巩固当前的知识.
主要方法:
- 现有文献的叙述性审查.
- 诊断方法的分析,包括凝血测试和FV活动测试.
- 检查F5基因内的遗传突变.
主要成果:
- FV缺乏症呈现出不同的临床症状,从轻微的伤到严重的出血,如内出血.
- 诊断依赖于凝血查和特定的FV活动测试.
- 基因分析确定了F5基因中的多种突变.
结论:
- 遗传FV缺陷需要全面的诊断方法.
- 管理策略侧重于新鲜冷的血,最好是病毒失活的.
- 了解分子基础和临床范围对于有效的患者护理至关重要.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
654
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654
Disorders of Hemostasis
756
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
756
Coagulation
5.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
5.6K
Extrinsic and Intrinsic Pathways of Hemostasis
6.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.5K
Clot Retraction and Fibrinolysis
4.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.9K
Structure and Function of Platelets
1.1K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.1K


